With a coronavirus vaccine still months away, the two-Ts – testing and tracing – remain critically important elements in controlling the outbreak, and by extension minimizing fatalities.
In our latest One2One Virtual Forum we have five companies at the forefront of developing rapid solutions for testing and real-time track and trace that puts privacy at its heart.
This is a not-to-be-missed opportunity to find out what’s new in the battle against this pernicious virus.
Join us at 1pm EST on Tuesday, October 27, from 1pm to hear more.
Victory Square Technologies Inc: A Covid vaccine is still months away; meet a company preparing to wage war against the coronavirus
Victory Square Technologies Inc (CNSX:VEST) has gone from 14 cents to 64 cents in less than two months – and for good reason.
Its portfolio company, Victory Square Health, has come up with a 15-minute COVID-19 test that boasts 96.6% sensitivity.
And, hot off the press, Victory’s Safetest technology has received the official green light for distribution in the 27 countries of the European Union.
Meet Victory Square Technologies’ chief growth officer, Vahid Shababi, at the Proactive Virtual Forum.
Contakt World: Here’s a technology that may prove the difference between success and failure in fighting COVID-19
The difference between success and failure in fighting COVID-19 has been an effective track and trace program.
Contakt World has developed real-time contact tracing for government agencies and business that’s both efficient and accurate.
Crucially, privacy is guaranteed by using blockchain technology to preserve personal information from unauthorized use.
Chief executive Justin Beck will be joining us at the Proactive Virtual Forum on Tuesday October 27, from 1pm EST.
Could LexaGene Holdings Inc’s pathogen detection platform be a difference-maker in the fight against COVID-19?
LexaGene Holdings Inc (CVE:LXG, OTCMKTS:LXXGF) is at the leading edge of med-tech in pioneering the first fully-automated pathogen detection platform for use in diagnostics and sample analysis.
While its MiQLab doesn’t have regulatory sign-off for human clinical diagnostics, LexaGene is pursuing an FDA emergency use authorization for Covid testing, which would open a whole new window of opportunity.
In the meantime, it recently launched an early access program for its MiQLab aimed at the veterinary and open-access markets.
To hear more from CEO and founder Jack Regan, sign up for the Proactive Virtual Forum on Tuesday October 27.
BioPorto Diagnostics A/S is helping develop a ten-minute coronavirus test that could be on the market by the year-end
BioPorto Diagnostics A/S (CPH:BIOPOR) shares have almost doubled in value in little over a month, reflecting the progress it has made with its ten-minute COVID-19 test.
This potentially ground-breaking technology is being developed in harness with the University of Southern Denmark, which brings to the party its antibody expertise.
If successful, the company intends to file for fast-track emergency use in the US along and is pursuing official sign-off for the device in Europe too.
All of this means BioPorto could have its ten-minute test out on the market by the end of the year.
Chief medical officer Christopher Bird will explain all when he presents to the Proactive Virtual Forum on Tuesday October 27, from 1pm EST.
XPhyto Therapeutics Corp could have its rapid disposable coronavirus test on the market early next year
XPhyto Therapeutics Corp (CSE:XPHY, OTCQB:XPHYF, FRA:4XT) has partnered with a company called 3a-Diagnostics to develop a rapid disposable COVID-19 test.
Work has progressed so rapidly in recent weeks the pair are targeting regulatory approval for the product in the first three months of next year.
Bringing us up to date on progress with areas such as advanced prototype production and usability testing will be CEO Hugh Rogers.
Catch up with Hugh at the Proactive Virtual Forum on Tuesday October 27, from 1pm EST.
About the event:
- Ours is an audience of astute high net worth investors, fund managers, private client brokers and analysts
- We look beyond the numbers and meet the people creating the value for shareholders
- Each company has a presentation slot followed by Q & A, giving you the chance to discover the real story
- You can watch the event afterwards on our YouTube channel